Presentation / Fact Sheet
Upcoming Events
Past Events
Tribe Public’s Webinar Presentation and Q&A Event
May 28, 2026
Ebola, Marburg, Hantavirus, Mpox and Beyond: Building a Resilient Infectious Disease Preparedness Strategy
Biotech Showcase
| January 13, 2026, 2:30 pm PST |
| Webcast |
World Vaccine Congress Europe 2025
October 13 - 16, 2025
Amsterdam, Netherlands
Mark J. Newman, PhD
Presentation: “Vaccine design to address the immunocompromised: T-lymphocyte driven…Balanced immunity - Broader specificity – Increased memory.”
Kelly T. McKee, Jr., MD, MPH
Presentation: “Interim Safety and Reactogenicity of GEO-CM04S1, an MVA-vectored, multi-antigen COVID-19 vaccine, in adults with hematologic malignancies receiving cellular therapies.”
4th Annual ROTH Healthcare Opportunities Conference
| October 9, 2025 |
| New York, NY |
Emerging Growth Conference
International Workshop on Chronic Lymphocytic Leukemia (iwCLL 2025)
Presenter: Alexey V. Danilov, MD, PhD; Professor, Department of Hematology and Transplantation; City of Hope National Medical Center, Duarte, California
Topic: MVA-based GEO-CM04S1 vaccine results in improved cellular immune response in patients with chronic lymphocytic leukemia (CLL) compared with mRNA-based vaccine: initial results from a Phase II randomized study.
6th ESCMID Conference on Vaccines: From Development to Real-World Clinical Practice and Global Health
Presenter: Kelly T. McKee, Jr., MD, MPH; Chief Medical Officer, GeoVax Labs, Atlanta, Georgia
Topic: GEO-CM04S1, a multi-antigen COVID-19 vaccine for immunocompromised individuals: clinical evaluation to date.